Previous 10 | Next 10 |
home / stock / lbltf / lbltf news
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q1 2019, and preliminary revenues for Q2 2019. Sales and Product Offerings Completion of the relocated processing facili...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for the fiscal year end 2018 and preliminary revenues for Q1 2019. Sales and Product Offerings Successfully relocated proces...
Lattice Biologics ( OTCPK:LBLTF ): Q3 GAAP EPS of -$0.01. More news on: Lattice Biologics Ltd, Earnings news and commentary, Healthcare stocks news, , Read more ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for the three and nine months ending June 2018. Sales and Product Offerings Successfully relocated processing facility to Be...
Lattice Biologics ( OTCPK:LBLTF ): Q2 EPS of $0.00 More news on: Lattice Biologics Ltd, Earnings news and commentary, Healthcare stocks news, , Read more ...
Gross Margins Increase to 68% Q2 2018 from 30% Q2 2017 Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for the second quarter 2018. Highlights: Gross profit margin wa...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces the Company has successfully filed all necessary reporting documents and the preceding MCTO was revoked as of May 1, 2018. For the past few months, the ...
Lattice Biologics ( OTCPK:LBLTF ): Q1 EPS of $0.00. More news on: Lattice Biologics Ltd, Earnings news and commentary, Healthcare stocks news, , Read more ...
Gross Margins Increase to 66% Q1 2018 from 37% Q1 2017 Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for the fourth quarter 2017, year ended September 30, 2017, and first quarte...
Lattice Biologics Ltd. ( TSX-V: LBL ) ( OTCQB: LBLTF ) (“ Lattice Biologics ” or the “ Company ”) is providing this default status report in accordance with National Policy 12-203 – Management Cease Trade Orders. The Company’s audited annual...
News, Short Squeeze, Breakout and More Instantly...
Lattice Biologics Ltd Company Name:
LBLTF Stock Symbol:
OTCMKTS Market:
Late in the trading day on Friday, July, 9, Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) issued an update on the company which has been unable to trade its stock for over a month. The company had originally made biologic products for use in the field of bone regeneration i...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2021. Highlights of Six Months Ended March 31, 2021 Sales and Product Offerings ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice” or the “Company”), an emerging leader in psilocybin research and cannabis company, today announced the formation of its Strategic Advisory Board, a group of respected business leaders that wi...